Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
MGNX
#3182
MacroGenics, Inc.
1.9
9
+1.53%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+1.53%
Variazione Mensile
+8.15%
Variazione di 6 mesi
+13.71%
Variazione Annuale
-17.43%
Chiusura Precedente
1.9
6
Open
1.9
9
Bid
Ask
Low
1.9
9
High
1.9
9
Volume
16
Mercati
Mercato Azionario Statunitense
Salute
MGNX
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
62.76 M
63.09 M
63.09 M
63.21 M
63.26 M
—
Valuation ratios
Enterprise value
26.87 M
22.2 M
-65.45 M
-54.21 M
26.15 M
-71.3 M
Price to earnings ratio
-2.1
-3.04
-1.44
-2.16
-1.41
-8.05
Price to sales ratio
1.46
1.36
0.52
0.46
0.83
3.17
Price to cash flow ratio
-3.51
-2.98
-1.14
-1.06
-0.65
-5.83
Price to book ratio
0.47
1.75
0.21
0.21
0.34
2.52
Enterprise value to EBITDA ratio
0.29
0.26
-0.7
-0.49
0.34
-0.59
Profitability ratios
Return on assets %
0.21
-0.37
0.18
0.15
0.06
0.02
Return on equity %
0.47
-0.84
0.52
0.78
0.25
0.71
Return on invested capital %
—
-2 197.92
—
193.79
59.56
—
Gross margin %
99.85
98.8
100
100
100
398.8
Operating margin %
48.95
-287
323.1
165.27
25.59
226.96
EBITDA margin %
88.77
-34.3
32.18
66.75
88.86
153.49
Net margin %
50.86
-502.23
311.07
162.99
23.09
-5.08
Liquidity ratios
Quick ratio
3.69
3.92
3.11
5.02
5.02
17.07
Current ratio
3.75
3.92
3.28
5.25
5.22
17.68
Inventory turnover
0.08
0.14
0
0
0
0.14
Asset turnover
0.48
0.07
0.05
0.09
0.28
0.5
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.96
0.61
0.74
0.74
0.48
2.58
EBIT per share
1.53
-0.14
0.04
0.2
0.99
1.1
EBITDA per share
1.56
-0.11
0.07
0.24
1.02
1.22
Total debt per share
—
—
—
—
—
—
Cash per share
2.86
2.92
2.31
2.07
1.27
8.57
Net current asset value per share
3.53
3.47
2.89
3.25
3.67
13.28
Tangible book value per share
1.91
1.85
1.26
0.74
1.06
4.91
Working capital per share
2.59
2.59
2.01
2.63
2.96
10.19
Book value per share
1.91
1.85
1.26
0.74
1.06
4.91
Notizie
BioLife Solutions, Inc. (BLFS) Surpasses Q4 Earnings and Revenue Estimates
Le azioni MacroGenics scendono dopo il blocco clinico parziale della FDA
MacroGenics stock falls after FDA places partial clinical hold
Why Is MacroGenics Stock Sinking Tuesday? - Macrogenics (NASDAQ:MGNX)
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children
Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3
MacroGenics (MGNX) Q3 Earnings and Revenues Surpass Estimates
Gli EPS di MacroGenics Inc hanno battuto le aspettative per 0,68$, il fatturato supera le previsioni
MacroGenics Inc earnings beat by $0.68, revenue topped estimates
MacroGenics (MGNX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Stryker (SYK) Q3 Earnings and Revenues Beat Estimates